Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cezary Cybulski

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Hereditary Cancer in Clinical Practice|September 4, 2009
Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of originCezary Cybulski
International Journal of Cancer|June 20, 2014
Multiple primary cancers as a guide to heritabilityCezary Cybulski, Safia Nazarali, Steven A Narod
International Journal of Cancer|December 13, 2016
BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAnessPawel Domagala, Jolanta Hybiak, Cezary Cybulski, et al.
Annales Academiae Medicae Stetinensis|January 9, 2009
[HLA-G alleles and risk of early pregnancy loss]Olimpia Sipak-Szmigiel, Cezary Cybulski, Elzbieta Ronin-Walknowska, et al.
Hereditary Cancer in Clinical Practice|January 22, 2021
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: updateAlena Savanevich, Olgierd Ashuryk, Cezary Cybulski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 9, 2011
A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL geneKrzysztof Majchrzak, Cezary Cybulski, Barbara Bobek-Billewicz, et al.
International Journal of Molecular Sciences|April 28, 2023
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNAJoanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz-Tretyn, et al.
Hereditary Cancer in Clinical Practice|December 12, 2013
Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephoneAnna Galor, Cezary Cybulski, Jan Lubiński, et al.
Oncotarget|September 15, 2016
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancersPawel Domagala, Jolanta Hybiak, Janusz Rys, et al.
Breast Cancer Research and Treatment|June 25, 2011
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancerPawel Domagala, Dominika Wokolorczyk, Cezary Cybulski, et al.
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Hereditary Cancer in Clinical Practice|September 4, 2009
Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of originCezary Cybulski
International Journal of Cancer|June 20, 2014
Multiple primary cancers as a guide to heritabilityCezary Cybulski, Safia Nazarali, Steven A Narod
International Journal of Cancer|December 13, 2016
BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAnessPawel Domagala, Jolanta Hybiak, Cezary Cybulski, et al.
Annales Academiae Medicae Stetinensis|January 9, 2009
[HLA-G alleles and risk of early pregnancy loss]Olimpia Sipak-Szmigiel, Cezary Cybulski, Elzbieta Ronin-Walknowska, et al.
Hereditary Cancer in Clinical Practice|January 22, 2021
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: updateAlena Savanevich, Olgierd Ashuryk, Cezary Cybulski, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 9, 2011
A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL geneKrzysztof Majchrzak, Cezary Cybulski, Barbara Bobek-Billewicz, et al.
International Journal of Molecular Sciences|April 28, 2023
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNAJoanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz-Tretyn, et al.
Hereditary Cancer in Clinical Practice|December 12, 2013
Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephoneAnna Galor, Cezary Cybulski, Jan Lubiński, et al.
Oncotarget|September 15, 2016
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancersPawel Domagala, Jolanta Hybiak, Janusz Rys, et al.
Breast Cancer Research and Treatment|June 25, 2011
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancerPawel Domagala, Dominika Wokolorczyk, Cezary Cybulski, et al.
Pageof 31